hepat
b
viru
hbv
dna
viru
infect
liver
primari
target
current
high
affin
receptor
hbv
still
unknown
dendrit
cell
specif
ctype
lectin
dcsign
involv
pathogen
recognit
mannos
fucos
contain
carbohydr
lead
induct
antivir
immun
respons
mani
glycosyl
virus
subvert
immun
surveil
function
exploit
dcsign
port
entri
transinfect
target
cell
glycosyl
pattern
hbv
surfac
antigen
hbsag
togeth
tissu
distribut
hbv
would
allow
interact
hbv
dcsign
liverexpress
homologu
lsign
therefor
detail
studi
investig
bind
hbv
dcsign
lsign
perform
hcv
dcsign
lsign
known
bind
envelop
glycoprotein
solubl
dcsign
lsign
specif
bound
hcv
viruslik
particl
interact
either
hbsag
hbv
detect
also
neither
dcsign
lsign
transfect
raji
cell
bound
hbsag
contrast
highli
mannosyl
hbv
obtain
treat
hbv
produc
cell
amannosidas
inhibitor
kifunensin
recogn
dcsign
amannosidas
trim
nlink
oligosaccharid
structur
thu
prevent
recognit
dcsign
basi
find
tempt
specul
hbv
exploit
mannos
trim
way
escap
recognit
dcsign
therebi
subvert
possibl
immun
activ
respons
hepat
b
viru
hbv
infect
liver
primari
target
result
major
case
selflimit
acut
hepat
nevertheless
million
peopl
chronic
infect
hbv
worldwid
despit
high
incid
infect
cellular
receptor
hbv
entri
still
unknown
sever
put
bind
factor
describ
hbv
surfac
antigen
hbsag
human
serum
albumin
asialoglycoprotein
receptor
heparin
mannos
bind
lectin
exact
role
hbv
attach
uptak
remain
unclear
hepat
b
viru
dna
viru
consist
core
particl
envelop
small
middl
larg
l
surfac
antigen
gener
refer
hbsag
three
surfac
antigen
contain
common
domain
l
protein
contain
domain
l
exclus
contain
domain
liver
peripher
blood
hbv
infect
individu
reach
level
infecti
particl
per
ml
addit
hbsag
secret
infect
hepatocyt
spheric
subvir
particl
filament
accumul
lg
ml
peripher
blood
main
compon
hbv
virion
hbsag
subvir
particl
l
highli
enrich
hbv
virion
posttransl
modif
surfac
antigen
crucial
hbv
life
cycl
myristoyl
domain
essenti
infect
inhibit
nglycosyl
domain
prevent
secret
viral
particl
recent
posttransl
nglycosyl
domain
report
well
although
seem
dispens
hbv
morphogenesi
might
involv
viral
attach
first
step
clearanc
viral
infect
involv
recognit
viru
innat
immun
system
mediat
host
pattern
recognit
receptor
prr
tolllik
receptor
ctype
lectin
ctype
lectin
recogn
highli
conserv
pathogenderiv
carbohydr
structur
lead
intern
antigen
process
present
cell
prototyp
member
ctype
lectin
famili
dendrit
cellspecif
lectin
dcsign
recogn
broad
rang
glycosyl
pathogen
mannos
fucos
contain
carbohydr
includ
hepat
c
viru
hcv
ebola
viru
dengu
viru
measl
viru
human
herpesviru
sar
coronaviru
cytomegaloviru
mycobacterium
tubercolosi
helicobact
pylori
streptococcu
pneumonia
neisseria
meningitidi
outcom
interact
pathogendepend
mani
dcsignbind
pathogen
evolv
subvert
immun
surveil
function
dcsign
benefit
redirect
intern
rout
nonlysosom
compart
protect
transmiss
target
cell
pathogen
also
modul
adapt
immun
respons
interact
dcsign
eg
tuberculosi
exploit
dcsign
escap
immun
surveil
inhibit
immunostimulatori
function
dendrit
cell
well
establish
envelop
glycoprotein
hcv
interact
dcsign
homologu
lsign
express
sinusoid
endotheli
cell
liver
lymph
node
hcv
viruslik
particl
dcsign
interact
lead
effici
captur
intern
transport
nonlysosom
compart
within
immatur
dendrit
cell
therebi
protect
viru
degrad
similarli
hcv
viruslik
particl
interact
lsign
express
liver
sinusoid
endotheli
cell
lsec
situ
target
nonlysosom
earli
endosom
lsign
transfect
raji
cell
dcsign
lsign
also
thought
play
import
role
hcv
viral
dissemin
transfer
hcv
circul
hepatocyt
main
hcv
target
cell
sever
report
shown
presenc
hbv
within
dendrit
cell
suggest
involv
dendrit
cellspecif
receptor
dcsign
patientderiv
hbsag
preferenti
internalis
human
lsec
mix
cultur
human
hepatocyt
k
esser
u
protzer
unpublish
data
also
report
duck
hbv
impli
potenti
interact
hbv
lsign
hbv
glycosyl
pattern
togeth
cellular
local
prompt
us
investig
possibl
role
dcsign
lsign
bind
hbv
follow
antibodi
use
dcsign
lsign
specif
antibodi
mous
antidcsign
conjug
fluorescein
isothiocyan
fitc
clone
bd
bioscienc
san
jose
ca
usa
mous
antihcv
innogenet
ghent
belgium
sheep
antihbsag
mous
antihbsag
biotinyl
human
antihbsag
kind
gift
r
heijtink
erasmu
mc
rotterdam
netherland
rabbit
antihbsagfitc
acri
antibodi
gmbh
hiddenhausen
germani
peroxidaseconjug
goat
antihuman
immunoglobulin
jackson
immunoresearch
west
grove
pa
usa
peroxidaseconjug
rabbit
antifitc
dako
glostrup
denmark
peroxidaseconjug
goat
antimous
caltag
carlsbad
ca
usa
peroxidaseconjug
streptavidin
dako
recombin
hbv
surfac
antigen
hbsag
contain
domain
purifi
transfect
chines
hamster
ovari
cho
cell
kindli
provid
van
roosmalen
boxtel
netherland
yeast
cellderiv
hcv
glycoprotein
reconstitut
viruslik
particl
vlp
kindli
provid
depraeter
innogenet
cell
grown
confluenc
e
medium
gibco
paisley
uk
supplement
foetal
calf
serum
fc
hyclon
logan
ut
usa
secret
hbv
subvir
particl
concentr
medium
describ
final
concentr
hbv
particl
ml
enrich
hbv
subvir
particl
cultur
supernat
load
pb
equilibr
ml
bed
volum
hi
trap
tm
heparin
hp
column
ge
healthcar
bioscienc
ab
uppsala
sweden
fifteen
column
volum
pb
wash
hbv
particl
elut
ml
elut
buffer
mm
nacl
mm
trishcl
ph
collect
elut
fraction
ml
flow
rate
ml
min
elut
fraction
dialyz
pb
neg
control
procedur
follow
supernat
untransfect
cell
elut
fraction
assess
presenc
hbv
particl
l
sspecif
enzymelink
immunosorb
assay
elisa
captur
hbv
anti
specif
antibodi
respect
bound
hbv
detect
biotinyl
human
antihbsag
quantif
hbv
particl
done
coba
taqman
hbv
test
roch
diagnost
gmbh
mannheim
germani
viral
dna
isol
use
high
pure
system
viral
nucleic
acid
kit
roch
diagnost
penzberg
germani
gener
highli
mannosyl
hbv
cell
treat
amannosidas
inhibitor
kifunensin
day
lg
ml
calbiochem
darmstadt
germani
untreat
cell
kifunsin
treat
cell
serv
neg
control
final
concentr
highli
mannosyl
nativ
hbv
hbv
particl
ml
respect
stabl
raji
transfect
express
wildtyp
dcsign
lsign
gener
previous
describ
monocytederiv
dendrit
cell
modc
cultur
monocyt
presenc
gmcsf
u
ml
respect
scheringplough
brussel
belgium
day
phenotyp
cultur
modc
confirm
flow
cytometr
analysi
express
level
dcsign
lsign
transfect
raji
cell
modc
determin
flow
cytometri
dcsign
lsign
specif
antibodi
heparin
purifi
glycan
modifi
nativ
hbv
captur
elisa
plate
maxisorb
nunc
roskild
denmark
mous
recombin
hbsag
lg
well
hcv
vlp
lg
well
mannan
lg
well
sigmaaldrich
st
loui
mo
usa
coat
directli
onto
plate
h
block
bovin
serum
albumin
h
follow
biotinyl
plant
lectin
ad
h
room
temperatur
concentr
lg
ml
con
concavalin
recogn
aglucos
amannos
gna
galanthu
nivali
agglutinin
amannos
wga
wheat
germ
agglutinin
nacetylglucosamin
pna
arachi
hypogaea
agglutinin
bgalactos
nacetylgalactosamin
rcaii
ricinu
communi
agglutinin
bgalactos
nacetylgalactosamin
lta
lotu
tetragonolobu
agglutinin
fucos
sigma
aldrich
lectin
bind
detect
use
peroxidaseconjug
streptavidin
absorb
measur
nm
dcsignfc
bind
assay
perform
previous
describ
short
recombin
hbsag
lg
well
hbv
control
captur
maxisorb
elisa
plate
nunc
mous
hcv
vlp
lg
well
coat
directli
plate
block
bovin
serum
albumin
min
solubl
dcsignfc
ad
bound
dcsign
detect
incub
peroxidaselabel
antihuman
immunoglobulin
antibodi
specif
dcsignfc
bind
determin
block
either
mannan
lg
ml
sigmaaldrich
egta
mm
sigmaaldrich
assess
coat
effici
hbsag
hbv
detect
biotinyl
human
antihbsag
hcv
vlp
detect
mous
antihcv
hbv
concentr
centrifug
purifi
heparin
column
gave
similar
result
dcsignfc
bind
assay
solubl
dcsign
lsign
lysat
elisa
raji
dcsign
lsign
transfect
lyse
h
lysi
buffer
mm
nacl
mm
mgcl
mm
cacl
pb
supplement
ethylenediamin
tetraacet
acid
edta
free
proteas
inhibitor
roch
diagnost
hbsag
hbv
medium
control
captur
elisa
plate
mous
antibodi
hcv
vlp
coat
directli
plate
block
bovin
serum
albumin
min
raji
dcsign
lsign
lysat
ad
h
rt
bound
dcsign
lsign
detect
fitcconjug
dcsign
lsign
specif
antibodi
clone
follow
peroxidaseconjug
rabbit
antifitc
antibodi
specif
bind
determin
presenc
mannan
lg
ml
sigmaaldrich
assess
coat
effici
hbsag
hbv
hcv
vlp
detect
specif
antibodi
hbv
concentr
centrifug
purifi
heparin
column
gave
similar
result
solubl
dcsign
lsign
lysat
elisa
untransfect
raji
cell
dcsign
lsigntransfect
raji
cell
modc
incub
without
hbsag
lg
ml
h
bind
measur
flow
cytometri
intracellular
stain
antihbsagfitc
antibodi
acri
antibodi
gmbh
uptak
compar
lectinmedi
bind
dextranfitc
lg
ml
mw
molecular
probe
invitrogen
carlsbad
ca
usa
specif
bind
determin
min
preincub
mannan
lg
ml
secret
hbsag
subvir
particl
outnumb
hbv
virion
least
patient
serum
cultur
supernat
cell
enrich
hbv
virion
cultur
supernant
cell
fraction
heparin
column
differ
elut
fraction
assess
hbv
l
sspecif
elisa
input
fraction
contain
mainli
protein
repres
rel
high
level
secret
spheric
subvir
particl
fig
elut
fraction
howev
highli
enrich
l
protein
confirm
increas
level
hbv
virion
fraction
quantif
hbvdna
input
fraction
elut
fraction
confirm
almost
enrich
hbv
virion
fraction
hbv
particl
per
ml
fig
interact
dcsign
recombin
hbsag
hbv
determin
bind
elisa
coat
hbsag
hbv
hcv
vlp
medium
control
incub
solubl
recombin
dcsignfc
detect
signal
medium
control
never
background
strikingli
dcsign
interact
hbsag
whole
viru
particl
wherea
dcsign
interact
hcv
viruslik
particl
consist
purifi
yeast
recombin
hcv
envelop
protein
fig
specif
bind
determin
block
either
mannan
yeast
cell
deriv
polycarbohydr
competit
bind
carbohydr
bind
site
mannosespecif
lectin
calcium
chelat
egta
agent
inde
reduc
dcsign
bind
hcv
background
level
coat
control
demonstr
approxim
equal
amount
hbsag
hbv
hcv
vlp
coat
base
oligosaccharid
specif
sever
plant
lectin
use
glycan
analysi
hbsag
heparin
purifi
hbv
fig
strong
bind
con
gna
wga
pna
rcaii
lta
demonstr
presenc
high
complex
mannos
nacetylglucosamin
galactos
fucos
contain
carbohydr
structur
hbsag
hbv
dcsignglycoprotein
interact
high
mannos
fucos
contain
oligosaccharid
structur
import
note
carbohydr
structur
hcv
vlp
mannan
mainli
consist
mannos
indic
exclus
bind
con
gna
exclud
possibl
lack
interact
hbv
recombin
dcsign
improp
multimer
dcsignfc
bind
hbsag
hbv
nativ
dcsign
studi
dcsign
deriv
transfect
raji
cell
describ
flow
cytometr
analysi
raji
transfect
show
high
express
level
dcsign
fig
bind
elisa
coat
hbsag
hcv
vlp
incub
lysat
mock
dcsign
transfect
raji
cell
bound
dcsign
detect
antidcsign
antibodi
dcsign
deriv
raji
transfect
bind
hbsag
whole
hbv
particl
wherea
hcv
vlp
show
mannansensit
bind
dcsign
fig
control
incub
antihcv
antihbsag
specif
antibodi
indic
equal
amount
coat
background
bind
observ
either
hbsag
hcv
vlp
use
lysat
untransfect
raji
cell
data
shown
addit
elisa
hbsag
interact
cellular
dcsign
also
determin
dcsign
highli
express
modc
fig
therefor
rajidcsign
modc
incub
hbsag
bind
measur
flow
cytometri
neither
dcsignposit
raji
cell
modc
interact
hbsag
h
incub
fig
data
shown
contrast
dcsigntransfect
raji
cell
modc
effici
internalis
dcsign
ligand
dextranfitc
mannansensit
manner
fig
mock
transfect
raji
cell
remain
dextranfitc
neg
data
shown
figur
summar
result
two
independ
bind
assay
similar
manner
interact
cellular
lsign
hbsag
hbv
determin
use
lsigntransfect
raji
cell
flow
cytometr
analysi
show
lsign
express
level
equal
dcsign
express
fig
solubl
lsign
interact
neither
hbv
hbsag
elisa
wherea
lsign
interact
hcv
vlp
fig
medium
control
alway
background
level
moreov
cellular
lsign
express
raji
transfect
bind
hbsag
bound
dextranfitc
mannansensit
manner
fig
thu
neither
hbsag
hbv
interact
dcsign
lsign
wherea
ctype
lectin
interact
hcv
virus
data
suggest
nlink
glycosyl
hbv
distinct
virus
evalu
whether
inde
nativ
hbv
glycosyl
meet
requir
dcsign
interact
glycan
modifi
hbv
gener
treat
hbvproduc
cell
amannosidas
inhibitor
kifunensin
kifunensin
caus
accumul
man
glcnac
oligosaccharid
glycoprotein
inhibit
mannos
trim
endoplasm
reticulum
carbohydr
analysi
glycan
modifi
hbv
inde
demonstr
increas
amount
mannos
structur
compar
nativ
hbv
shown
twofold
increas
bind
mannosespecif
plant
lectin
con
gna
bind
nacetylglucosaminespecif
lectin
wga
unchang
fig
control
incub
antihbsag
specif
antibodi
show
similar
amount
nativ
highli
glycosyl
hbv
coat
fig
interact
highli
mannosyl
hbv
dcsign
studi
dcsignfcbas
elisa
fig
strikingli
hbv
bind
dcsign
observ
kifunensin
treatment
viru
produc
cell
bind
could
inhibit
mannan
egta
protein
structur
hbv
therefor
compat
dcsign
bind
nativ
glycosyl
exclus
determin
dcsign
interact
observ
also
exclud
possibl
lack
dcsignhbv
interact
observ
due
low
sensit
dcsign
assay
use
studi
supernat
untreat
cell
show
bind
dcsign
minor
background
bind
observ
supernat
kifunensinetr
cell
due
accumul
larg
amount
highli
mannosyl
protein
medium
treatment
data
indic
mannos
trim
oligosaccharid
structur
present
hbv
prevent
interact
dcsign
one
key
question
hbv
biolog
focus
attach
entri
mechan
use
hbv
infect
hepatocyt
main
target
cell
sever
put
bind
receptor
propos
none
confirm
high
affin
receptor
hbv
relat
issu
hbv
entri
way
hbv
reach
hepatocyt
direct
contact
hbv
circul
hepatocyt
possibl
fenestr
lsec
cell
type
involv
hbv
dissemin
similar
hiv
transport
dendrit
cell
transinfect
cell
hcv
captur
lsec
promot
infect
hepatocyt
sinc
hbsag
glycoprotein
involv
ctype
lectin
receptor
viral
recognit
seem
plausibl
bestcharacteris
ctype
lectin
dendrit
cellexpress
dcsign
lsecexpress
homologu
lsign
capabl
recogn
broad
rang
glycosyl
pathogen
includ
virus
bacteria
protozoa
fact
hbv
found
attach
glycan
analysi
untreat
mannosyl
hbv
mannosespecif
lectin
con
gna
nacetylglucosaminespecif
lectin
wga
coat
control
captur
amount
untreat
mannosyl
hbv
detect
antihb
specif
antibodi
c
interact
highli
mannosyl
hbv
dcsign
studi
dcsignfc
elisa
describ
fig
specif
bind
determin
presenc
mannan
egta
supernat
untransfect
cell
shown
medium
control
data
shown
mean
sd
duplic
measur
one
repres
experi
three
shown
dendrit
cell
lsec
lead
dcsign
lsign
like
candid
receptor
present
studi
conclus
show
lack
interact
dcsign
purifi
hbv
nativ
glycosyl
moreov
recombin
hbsag
recogn
neither
dcsign
lsign
glycan
analysi
hbv
hbsag
demonstr
lack
dcsign
bind
due
aberr
glycosyl
virion
glycoprotein
use
studi
sinc
observ
glycosyl
pattern
consist
previous
report
complextyp
carbohydr
structur
hbv
notabl
mannos
nacetylglucosamin
seem
present
similar
amount
hbv
hbsag
glycan
structur
virion
enrich
galactos
nacetylgalactosamin
fucos
differ
observ
glycosyl
pattern
might
result
oglycan
present
domain
dcsign
shown
interact
high
mannosecontain
glycan
variou
virus
hcv
hiv
ebola
even
though
data
demonstr
virus
exploit
dcsign
benefit
major
captur
viru
degrad
rout
antigen
present
pathway
therebi
allow
induct
antivir
immun
respons
although
hbv
glycoprotein
involv
viral
recognit
known
bind
mannos
bind
lectin
asialoglycoprotein
receptor
shown
amannosidas
trim
nlink
oligosaccharid
structur
prevent
recognit
dcsign
hbv
thu
recogn
dcsign
soon
one
enzym
format
complex
glycan
amannosidas
inhibit
highli
mannosyl
virion
gener
previou
report
shown
import
hbv
glycosyl
viral
secret
inde
observ
decreas
secret
highli
mannosyl
vs
nativ
hbv
similar
cultur
condit
rule
patient
sera
contain
subpopul
highli
glycosyl
viremia
would
allow
interact
dcsign
preliminari
data
hbv
deriv
sever
patient
sera
high
viral
load
show
bind
dcsignfc
data
shown
therebi
indic
dcsign
may
involv
recognit
hbv
vivo
either
basi
find
tempt
specul
hbv
exploit
mannos
trim
way
escap
recognit
dcsign
therebi
subvert
possibl
immun
activ
respons
studi
need
address
issu
